These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 26299086)
21. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients. Xiong L; Chen QQ; Cheng Y; Lan YS; Yang JB; Wen XQ; Xie X; Kang T; Wu WH; Ou S BMC Nephrol; 2023 Aug; 24(1):238. PubMed ID: 37582785 [TBL] [Abstract][Full Text] [Related]
22. Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience. Liangos O; Kirchhoff S; Buchholz J; Ketteler M Kidney Blood Press Res; 2018; 43(4):1222-1230. PubMed ID: 30071519 [TBL] [Abstract][Full Text] [Related]
23. Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study. Wei S; Pan X; Wei J BMC Endocr Disord; 2024 Sep; 24(1):179. PubMed ID: 39237970 [TBL] [Abstract][Full Text] [Related]
24. Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone. Inaba M; Okuno S; Nagayama H; Yamada S; Ishimura E; Imanishi Y; Shoji S J Ren Nutr; 2015 Mar; 25(2):242-6. PubMed ID: 25556148 [TBL] [Abstract][Full Text] [Related]
25. Correlation of new bone metabolic markers with conventional biomarkers in hemodialysis patients. Takano M; Okano K; Tsuruta Y; Yamashita T; Echida Y; Miwa N; Kimata N; Akiba T; Nitta K Clin Invest Med; 2011 Oct; 34(5):E267. PubMed ID: 21968268 [TBL] [Abstract][Full Text] [Related]
26. The importance of bone biomarkers in the diagnosis of renal osteodystrophy. Pena YT; Soyibo AK; McGrowder D; Clarke TR; Barton EN West Indian Med J; 2010 Jun; 59(3):332-7. PubMed ID: 21291118 [TBL] [Abstract][Full Text] [Related]
28. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis. Rhee CM; Molnar MZ; Lau WL; Ravel V; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K Perit Dial Int; 2014; 34(7):732-48. PubMed ID: 24385335 [TBL] [Abstract][Full Text] [Related]
29. Does PTH offer additive value to ALP measurement in assessing CKD-MBD? Lamb EJ; Delaney MP Perit Dial Int; 2014; 34(7):687-91. PubMed ID: 25520480 [No Abstract] [Full Text] [Related]
30. CHARACTERISTICS OF CALCIUM-PHOSPHORUS METABOLISM AND BONE TURNOVER INDICATORS IN PATIENTS WITH LIVER CIRRHOSIS AND THEIR DIAGNOSTIC VALUE FOR ASSESSING BONE STRUCTURES DISORDER. Drobinska N; Abrahamovych O; Abrahamovych M; Ivanochko R; Chemes V Georgian Med News; 2023 Jan; (334):41-48. PubMed ID: 36864791 [TBL] [Abstract][Full Text] [Related]
31. Mineral bone disorder and osteoporosis in hemodialysis patients. Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689 [TBL] [Abstract][Full Text] [Related]
32. Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients. Sardiwal S; Gardham C; Coleman AE; Stevens PE; Delaney MP; Lamb EJ Kidney Int; 2012 Jul; 82(1):100-5. PubMed ID: 22456600 [TBL] [Abstract][Full Text] [Related]
33. Parathormone and bone-specific alkaline phosphatase for the follow-up of bone turnover in hemodialysis patients: is it so simple? Delanaye P; Dubois BE; Jouret F; Krzesinski JM; Moranne O; Cavalier E Clin Chim Acta; 2013 Feb; 417():35-8. PubMed ID: 23262367 [TBL] [Abstract][Full Text] [Related]
34. Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients. Jeong JU; Lee HK; Kim YJ; Kim JS; Kang SS; Kim SB Clin Nephrol; 2010 Nov; 74(5):336-42. PubMed ID: 20979940 [TBL] [Abstract][Full Text] [Related]
35. Impact of treatment with active vitamin D calcitriol on bone turnover markers in people with type 2 diabetes and stage 3 chronic kidney disease. Stathi D; Fountoulakis N; Panagiotou A; Maltese G; Corcillo A; Mangelis A; Ayis S; Gnudi L; Karalliedde J Bone; 2023 Jan; 166():116581. PubMed ID: 36216304 [TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients. Thisiadou K; Liakopoulos V; Dimas G; Koliakos G; Karamouzis M Hippokratia; 2017; 21(1):25-31. PubMed ID: 29904253 [TBL] [Abstract][Full Text] [Related]
37. [A Cross-sectional Study of Osteoporosis and Cardiovascular Calcification in Patients with Chronic Kidney Disease at Different CKD Stages]. Cai ZY; Hu XF; Chen LQ; Li ZR; Du XG Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):334-339. PubMed ID: 33829711 [TBL] [Abstract][Full Text] [Related]
38. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis. Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637 [TBL] [Abstract][Full Text] [Related]
39. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623 [TBL] [Abstract][Full Text] [Related]
40. No Associations of 25-Hydroxycholecalciferol and Parathyroid Hormone Concentrations with Calcaneal Bone Characteristics in Community-Dwelling Elderly Subjects: A Cross-Sectional Study. Jungert A; Neuhäuser-Berthold M J Nutr Health Aging; 2017; 21(6):733-742. PubMed ID: 28537341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]